selected scholarly activity
-
academic article
- Hypertension Canada’s 2018 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults and Children. Canadian Journal of Cardiology. 34:506-525. 2018
- Hypertension Canada's 2017 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults (vol 33, pg 557, 2017). Canadian Journal of Cardiology. 33:1733-1734. 2017
- Ovarian torsion in children. Medicine (United States) Medicine. 96:e8299-e8299. 2017
- Hypertension Canada's 2017 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults. Canadian Journal of Cardiology. 33:557-576. 2017
- Hypertension Canada's 2016 Canadian Hypertension Education Program Guidelines for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension. Canadian Journal of Cardiology. 32:569-588. 2016
- A New Algorithm for the Diagnosis of Hypertension in Canada. Canadian Journal of Cardiology. 31:620-630. 2015
- The 2015 Canadian Hypertension Education Program Recommendations for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension. Canadian Journal of Cardiology. 31:549-568. 2015
- MEthods of ASsessing blood pressUre: identifying thReshold and target valuEs (MeasureBP): A Review & Study Protocol. Current Hypertension Reports. 17:533. 2015
- Treatment of dyslipidemia: The problem of reaching the goal. Atherosclerosis. 236:142-143. 2014
- Treatment of dyslipidemia: the problem of reaching the goal.. Atherosclerosis. 236:142-143. 2014
- The Role of Adiponectin in Endothelial Dysfunction and Hypertension. Current Hypertension Reports. 16:463. 2014
- The 2014 Canadian Hypertension Education Program Recommendations for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension. Canadian Journal of Cardiology. 30:485-501. 2014
- The 2013 Canadian Hypertension Education Program Recommendations for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension. Canadian Journal of Cardiology. 29:528-542. 2013
- Targeting Hypertension in Patients with Cardiorenal Metabolic Syndrome. Current Hypertension Reports. 14:397-402. 2012
- The 2012 Canadian Hypertension Education Program Recommendations for the Management of Hypertension: Blood Pressure Measurement, Diagnosis, Assessment of Risk, and Therapy. Canadian Journal of Cardiology. 28:270-287. 2012
- The 2011 Canadian Hypertension Education Program Recommendations for the Management of Hypertension: Blood Pressure Measurement, Diagnosis, Assessment of Risk, and Therapy. Canadian Journal of Cardiology. 27:415-433.e2. 2011
- Do Recommendations for the Management of Hypertension Improve Cardiovascular Outcome? The Canadian Experience. International Journal of Hypertension. 2011:1-3. 2011
- Antihypertensive treatment in patients with cerebrovascular disease: the lower the better?. Journal of Hypertension. 28:1380-1381. 2010
- The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I – blood pressure measurement, diagnosis and assessment of risk. Canadian Journal of Cardiology. 26:241-248. 2010
- The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1 – blood pressure measurement, diagnosis and assessment of risk. Canadian Journal of Cardiology. 25:279-286. 2009
- Treatment Resistant Hypertension. American Journal of Therapeutics. 15:351-355. 2008
- The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1 – blood pressure measurement, diagnosis and assessment of risk. Canadian Journal of Cardiology. 24:455-463. 2008
- High normal blood pressure and prehypertension: The debate continues. Canadian Journal of Cardiology. 23:581-583. 2007
- The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1 – blood pressure measurement, diagnosis and assessment of risk. Canadian Journal of Cardiology. 23:529-538. 2007
- Treatment resistant hypertension. Revista Latinoamericana de Hipertension. 2:93-97. 2007
- Masked hypertension: A common but insidious presentation of hypertension. Canadian Journal of Cardiology. 22:617-620. 2006
- The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I – Blood pressure measurement, diagnosis and assessment of risk. Canadian Journal of Cardiology. 22:573-581. 2006
- New Algorithm for the Diagnosis of HypertensionCanadian Hypertension Education Program Recommendations (2005). American Journal of Hypertension. 18:1369-1374. 2005
- Applying the 2005 Canadian Hypertension Education Program recommendations: 1. Diagnosis of hypertension. CMAJ. 173:480-483. 2005
- The question of the role of ethnicity on cardiovascular risk: does it matter where we come from?. Journal of Hypertension. 23:1331-1333. 2005
- The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part 1- blood pressure measurement, diagnosis and assessment of risk.. Canadian Journal of Cardiology. 21:645-656. 2005
- Effectiveness of multidisciplinary patient counselling in reducing cardiovascular disease risk factors through nonpharmacological intervention: results from the Healthy Heart Program.. Canadian Journal of Cardiology. 20:177-186. 2004
- The 2004 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I--Blood pressure measurement, diagnosis and assessment of risk.. Canadian Journal of Cardiology. 20:31-40. 2004
- The 2001 Canadian Hypertension Recommendations - What is new and what is old but still important. Canadian Journal of Cardiology. 18:591-596. 2002
- The 2001 Canadian recommendations for the management of hypertension: Part one--Assessment for diagnosis, cardiovascular risk, causes and lifestyle modification.. Canadian Journal of Cardiology. 18:604-624. 2002
- The 2000 Canadian recommendations for the management of hypertension: part two--diagnosis and assessment of people with high blood pressure.. Canadian Journal of Cardiology. 17:1249-1263. 2001
- The 2000 Canadian hypertension recommendations: A summary. Canadian Journal of Cardiology. 17:535-538. 2001
- 1999 Canadian recommendations for the management of hypertension. CMAJ. 161:S1-S17. 1999
- Clarithromycin-digoxin interaction - Reply. Annals of Pharmacotherapy. 33:1375-1376. 1999
- Concomitant Digoxin Toxicity and Warfarin Interaction in a Patient Receiving Clarithromycin. Annals of Pharmacotherapy. 33:796-799. 1999
- Lifestyle modifications to prevent and control hypertension. 6. Recommendations on potassium, magnesium and calcium. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada.. CMAJ. 160:S35-S45. 1999
- Recommendations on potassium, magnesium and calcium. CMAJ. 160:S35-S45. 1999
- 1999 Canadian recommendations for the management of hypertension. Task Force for the Development of the 1999 Canadian Recommendations for the Management of Hypertension.. CMAJ. 161 Suppl 12:S1-17. 1999
- Patterns of compliance with once versus twice daily antihypertensive drug therapy in primary care: a randomized clinical trial using electronic monitoring.. Canadian Journal of Cardiology. 13:914-920. 1997
- Measurement of forearm blood flow.. Hypertension. 27:313. 1996
- The Effects of Posture Change and Continuous Positive Airway Pressure on Cardiac Natriuretic Peptides in Congestive Heart Failure. Chest. 107:909-915. 1995
- Serum Lipid Profile Determines Platelet Reactivity to Native and Modified LDL-Cholesterol in Humans. Thrombosis and Haemostasis. 71:627-632. 1994
- Ischemic ECG changes are found more often in asymptomatic men with a coronary prone behaviour pattern. Journal of Psychosomatic Research. 37:355-360. 1993
- Temperature-dependence of LDL binding and activation of human platelets. Thrombosis Research. 64:503-508. 1991
- EFFECTIVENESS AND TOLERABILITY OF ONCE VERSUS TWICE DAILY NITRENDIPINE IN THE TREATMENT OF MILD TO MODERATE HYPERTENSION. Canadian Journal of Cardiology. 7:59-64. 1991
- Effectiveness and tolerability of once versus twice daily nitrendipine in the treatment of mild to moderate hypertension. The Canadian Nitrendipine Study Group.. Canadian Journal of Cardiology. 7:59-64. 1991
- Once- vs. Twice-Daily Nitrendipine in the Treatment of Mild to Moderate Hypertension. Journal of Cardiovascular Pharmacology. 17:S182-S185. 1991
- Once- vs. twice-daily nitrendipine in the treatment of mild to moderate hypertension, Canadian Nitrendipine Study Group.. Journal of Cardiovascular Pharmacology. 17 Suppl 2:S182-S185. 1991
- Correlation of forearm vascular and catecholamine responses of hypertensive patients to baroreceptor stimulation.. Canadian Journal of Cardiology. 6:229-235. 1990
- Relations between sympathetic activation and plasma atrial natriuretic factor in man.. Cardioscience. 1:145-149. 1990
- The 24 h blood pressure responses of hypertensives to a once-a-day cilazapril regimen.. Canadian Journal of Cardiology. 6:53-58. 1990
- Cilazapril inhibits vascular responses to baroreflex-stimulated sympathetic neural activity in hypertensive patients.. Canadian Journal of Cardiology. 6:9-14. 1990
- MECHANISMS OF ACTION AND CLINICAL USE OF CALCIUM-ANTAGONISTS IN HYPERTENSION. Circulation. 80:136-144. 1989
- Mechanisms of action and clinical use of calcium antagonists in hypertension.. Circulation. 80:IV136-IV144. 1989
- The Vasodilating Effect of Atrial Natriuretic Peptide in Normotensive and Hypertensive Humans. Journal of Cardiovascular Pharmacology. 13:S75-S79. 1989
- Bevantolol attenuates thiazide stimulated renin secretion and catecholamine release in diuretic resistant hypertensives.. Canadian Journal of Cardiology. 5:93-97. 1989
- Comparative Effects of Haemodialysis and Haemofiltration on Plasma Atrial Natriuretic Peptide. Nephrology Dialysis Transplantation. 4:222-227. 1989
- Hemodynamic and adrenergic responses of bevantolol and propranolol in hypertensives.. Canadian Journal of Cardiology. 5:37-41. 1989
- Modulation of left ventricular hypertrophy by dietary salt and inhibition of angiotensin converting enzyme. Journal of Hypertension. 6:S145-147. 1988
- Pathophysiological role of atrial natriuretic peptide in man. Pharmacological Research Communications. 20:35-53. 1988
- Adrenaline and Enhanced Vasoconstriction in Patients with Essential Hypertension. Basic and Clinical Pharmacology and Toxicology Pharmacology and Toxicology. 63:41-44. 1988
- Fura-2 used as a probe to show elevated intracellular free calcium in platelets of Dahl-sensitive rats fed a high salt diet. Biochemical and Biophysical Research Communications. 154:380-386. 1988
- Can plasma catecholamine levels be a useful index of sympathetic nervous system activity?. Canadian Journal of Cardiology. 4:169-176. 1988
- A Roundatable Discussion Calcium Antagonists Alone or in Combination in Todayʼs Antihypertensive Therapy. Journal of Cardiovascular Pharmacology. 12:S101-S103. 1988
- Hemodynamic and Counterregulatory Effects of Calcium Antagonists in Hypertension. Journal of Cardiovascular Pharmacology. 12:S39-S43. 1988
- Impact of smoking on heart attacks, strokes, blood pressure control, drug dose, and quality of life aspects in the International Prospective Primary Prevention Study in Hypertension. American Heart Journal. 115:282-288. 1988
- Impact of smoking on heart attacks, strokes, blood pressure control, drug dose, and quality of life aspects in the International Prospective Primary Prevention Study in Hypertension.. American Heart Journal. 115:282-288. 1988
- Greater vasodilator responsiveness to atrial natriuretic peptide in low-renin essential hypertensives.. Journal of Hypertension, Supplement. 5:S55-S58. 1987
- Calcium antagonist induced vasodilation in peripheral, coronary and cerebral vasculature as important factors in the treatment of elderly hypertensives. European Heart Journal. 8:49-56. 1987
- ELECTROCARDIOGRAPHIC CHANGES DURING ANTIHYPERTENSIVE THERAPY IN THE INTERNATIONAL-PROSPECTIVE-PRIMARY-PREVENTION-STUDY-IN-HYPERTENSION. Hypertension. 9:69-74. 1987
- Electrocardiographic changes during antihypertensive therapy in the International Prospective Primary Prevention Study in Hypertension.. Hypertension. 9:III69-III74. 1987
- Mechanisms of Action of Calcium Antagonists in Hypertension. Journal of Cardiovascular Pharmacology. 10:S23-27. 1987
- The vasodilator potency of atrial natriuretic peptide in man. Circulation. 75:221-228. 1987
- ATRIAL-NATRIURETIC-PEPTIDE IS ELEVATED IN LOW-RENIN ESSENTIAL-HYPERTENSION. Journal of Hypertension. 4:S489-S491. 1986
- Calcium antagonists and the second drug for hypertensive therapy. American Journal of Medicine. 81:25-29. 1986
- Dose initiation of calcium antagonists in the treatment of hypertension.. J Clin Hypertens. 2:118S-124S. 1986
- Atrial Natriuretic Peptide and Atrial Pressure in Patients with Congestive Heart Failure. New England Journal of Medicine. 315:533-537. 1986
- Atrial antipressor natriuretic peptide: release mechanisms and vascular action in man.. Journal of Hypertension, Supplement. 4:S109-S114. 1986
- Acute and chronic sympathetic reflex activation and antihypertensive response to nifedipine. Journal of the American College of Cardiology. 7:344-348. 1986
- Calcium antagonism—A New concept for treating essential hypertension. American Journal of Cardiology. 57:D50-D53. 1986
- Abnormal cellular calcium regulation in essential hypertension.. Journal of Cardiovascular Pharmacology. 8 Suppl 8:S145-S149. 1986
- Cardiac and vascular beta-adrenoceptor-mediated responses before and during treatment with bisoprolol or atenolol.. Journal of Cardiovascular Pharmacology. 8 Suppl 11:S61-S64. 1986
- Plasma Lipid Fractions During Bopindolol Treatment in Hypertensive Patients. Journal of Cardiovascular Pharmacology. 8:S42-S44. 1986
- Withdrawal of the Long-Acting β Blocker Bopindolol Is Not Associated with β-Adrenoceptor Supersensitivity. Journal of Cardiovascular Pharmacology. 8:S64-S69. 1986
- Age, race, blood pressure and renin: Predictors for antihypertensive treatment with calcium antagonists. American Journal of Cardiology. 56:H81-H85. 1985
- Antihypertensive therapy and myocardial infarction: focus on calcium antagonists.. Journal of Hypertension, Supplement. 3:S95-S98. 1985
- Exercise and resting blood pressure and heart rate changes 24 h after dosing in patients with essential hypertension receiving 16/260 oxprenolol Oros once daily.. British Journal of Clinical Pharmacology. 19:207S-212S. 1985
- Vasodilatory effect of nicardipine and verapamil in the forearm of hypertensive as compared with normotensive man.. British Journal of Clinical Pharmacology. 20:62S-66S. 1985
- Adrenoceptors, calcium, and vasoconstriction in normal and hypertensive humans.. Journal of Cardiovascular Pharmacology. 7 Suppl 6:S130-S136. 1985
- Antihypertensive Treatment Using Calcium Antagonists in Combination with Captopril Rather than Diuretics. Journal of Cardiovascular Pharmacology. 7:S88-S91. 1985
- Calcium Antagonists and Renin-Angiotensin Inhibitors. Journal of Cardiovascular Pharmacology. 7:S1-S3. 1985
- Changes in cardiovascular responsiveness caused by age and high blood pressure: implications for therapy.. Journal of Cardiovascular Pharmacology. 7 Suppl 3:S206-S215. 1985
- Hemodynamic and Antihypertensive Treatment Responses with Calcium Antagonists. Journal of Cardiovascular Pharmacology. 7:S126-S130. 1985
- MODERATE HYPERTENSION. The Lancet. 2:948-948. 1985
- Position of Calcium Antagonists in Antihypertensive Therapy. Journal of Cardiovascular Pharmacology. 7:S21-S27. 1985
- The adrenaline -α 2 -adrenoceptor-mediated vasoconstrictor axis. Clinical Science. 68:141s-146s. 1985
- Adrenaline induces vasoconstriction through post-junctional alpha 2 adrenoceptors and this response is enhanced in patients with essential hypertension.. Journal of Hypertension, Supplement. 2:S115-S118. 1984
- Free calcium response to adrenaline in platelets of normal and hypertensive (untreated and treated) subjects.. Journal of Hypertension, Supplement. 2:S159-S161. 1984
- Renin profiling to select antihypertensive baseline drugs. Renin inhibitors for high-renin and calcium entry blockers for low-renin patients.. American Journal of Medicine. 77:36-42. 1984
- Use of Calcium Antagonists as Monotherapy in the Management of Hypertension. American Journal of Medicine. 77:11-15. 1984
- Correlation of Platelet Calcium with Blood Pressure. New England Journal of Medicine. 310:1084-1088. 1984
- Free calcium concentration in platelets closely relates to blood pressure in normal and essentially hypertensive subjects.. Hypertension. 6:I166-I166. 1984
- Free calcium concentration in platelets closely relates to blood pressure in normal and essentially hypertensive subjects.. Hypertension. 6:I166-I169. 1984
- Antihypertensive therapy with the long-acting calcium antagonist nitrendipine.. Journal of Cardiovascular Pharmacology. 6 Suppl 7:S1073-S1076. 1984
- Calcium influx blockers in the treatment of essential hypertension.. Acta Medica Scandinavica, Supplement. 681:101-108. 1984
- Efficacy and tolerance of the new long-acting vasodilator RO 12-4713 in hypertensive patients not managed on beta blockers and diuretics.. International Journal of Clinical Pharmacology Therapy and Toxicology. 22:13-15. 1984
- Enhanced alpha-adrenoceptor-mediated vasoconstriction contributes to increased vascular resistance in essential hypertension.. Netherlands Journal of Medicine. 27:140-145. 1984
- Forearm Vasoconstrictor Response to Ouabain. Journal of Cardiovascular Pharmacology. 6:S75-S75. 1984
- High Salt Intake Blunts Plasma Catecholamine and Renin Responses to Exercise. Journal of Cardiovascular Pharmacology. 6:S95-S95. 1984
- Parallel reduction of calcium-influx-dependent vasoconstriction and platelet-free calcium concentration with calcium entry and beta-adrenoceptor blockade.. Journal of Cardiovascular Pharmacology. 6 Suppl 7:S996-1001. 1984
- Plasma lipid fractions during long-term monotherapy with the ISA- containing beta-adrenoceptor blocker bopindolol in hypertensive patients.. British Journal of Clinical Pharmacology. 17:86-88. 1984
- Sympathetic nervous system in essential hypertension and antihypertensive response to alpha 2-adrenoceptor stimulation.. Journal of Cardiovascular Pharmacology. 6 Suppl 5:S753-S756. 1984
- TREATMENT OF HYPERTENSIVE HEART-DISEASE, FEATURING VASODILATORS. Therapeutische Umschau. Revue therapeutique. 41:150-155. 1984
- Calcium influx mediated vasoconstriction: studies in patients with mild and moderate essential hypertension.. Journal of Hypertension, Supplement. 1:105-108. 1983
- [Calcium antagonists: a potent vasodilatory principle and alternative basic antihypertensive therapy].. Swiss Medical Weekly Schweizerische Medizinische Wochenschrift. 113:1733-1735. 1983
- Factors influencing the hypotensive effects of calcium antagonists.. Hypertension. 5:II97-I102. 1983
- [Differential therapeutic aspects of high blood pressure therapy with beta blockers].. Schweizerische Rundschau f�r Medizin Praxis = Revue suisse de medecine Praxis. 72:684-690. 1983
- Hemodynamic and reflex responses to acute and chronic antihypertensive therapy with the calcium entry blocker nifedipine.. Hypertension. 5:I70-I70. 1983
- Hemodynamic and reflex responses to acute and chronic antihypertensive therapy with the calcium entry blocker nifedipine.. Hypertension. 5:I70-I74. 1983
- Alpha-Adrenoceptors, Adrenaline, and Exaggerated Vasoconstrictor Response to Stress in Essential Hypertension. Chest. 83:304-306. 1983
- ALPHA-ADRENOCEPTORS, ADRENALINE, AND EXAGGERATED VASOCONSTRICTOR RESPONSE TO STRESS IN ESSENTIAL-HYPERTENSION. Chest. 83:304-306. 1983
- BETA-BLOCKERS AND CALCIUM-ANTAGONISTS - CORNERSTONES OF ANTIHYPERTENSIVE THERAPY IN THE 1980S. Drugs. 25:50-57. 1983
- CHOICE OF BETABLOCKER FOR TREATMENT OF HIGH BLOOD-PRESSURE. Praxis. 72:684-690. 1983
- Effects of the Beta-Adrenoceptor-Blocking Agent Sotalol on Ventricular Arrhythmias in Patients with Chronic Ischemic Heart Disease. HeartDrug Cardiology. 70:114-121. 1983
- FACTORS INFLUENCING THE HYPOTENSIVE EFFECTS OF CALCIUM-ANTAGONISTS. Hypertension. 5:97-102. 1983
- Failure of prejunctional α2-adrenoceptor stimulation to reduce norepinephrine release in normal man. General Pharmacology: The Vascular System. 14:173-173. 1983
- Inhibition of the arteriolar smooth muscle Na+-K+-pump induces an enhanced vasoconstriction in borderline but not in established essential hypertension. General Pharmacology: The Vascular System. 14:193-196. 1983
- Verapamil-induced vasodilator response is enhanced in essential hypertension. General Pharmacology: The Vascular System. 14:185-188. 1983
- Effects of a new long-acting beta-blocker bopindolol (LT 31-200) on blood pressure, plasma catecholamines, renin and cholesterol in patients with arterial hypertension. European Journal of Clinical Pharmacology. 22:491-493. 1982
- Enhanced vasodilatation in essential hypertension by calcium channel blockade with verapamil.. Hypertension. 4:26-31. 1982
- Enhanced vasodilatation in essential hypertension by calcium channel blockade with verapamil.. Hypertension. 4:26-31. 1982
- Calcium channel inhibitors for identification of mechanisms and treatment of hypertension.. Journal of Cardiovascular Pharmacology. 4 Suppl 3:S267-S268. 1982
- Elevated adrenaline and increased alpha-adrenoceptor-mediated vasoconstriction in essential hypertension.. Journal of Cardiovascular Pharmacology. 4 Suppl 1:S134-S138. 1982
- GREATER ANTIHYPERTENSIVE EFFICACY OF THE CALCIUM-CHANNEL INHIBITOR VERAPAMIL IN OLDER AND LOW RENIN PATIENTS. Clinical Science. 63:S439-S442. 1982
- Personality and adrenergic factors in essential hypertension.. Contributions to Nephrology. 30:64-69. 1982
- Role of α-Adrenoceptor-Mediated Vasoconstriction for Antihypertensive β-Blockade. Journal of Cardiovascular Pharmacology. 4:S162-S167. 1982
- The place of the calcium antagonist verapamil in antihypertensive therapy.. Journal of Cardiovascular Pharmacology. 4 Suppl 3:S350-S357. 1982
- Verapamil-induced vasodilation is enhanced in essential hypertension.. Journal of Cardiovascular Pharmacology. 4 Suppl 3:S313-S318. 1982
- Lack of beta-adrenoreceptor hypersensitivity after abrupt withdrawal of long-term therapy with oxprenolol. Circulation. 64:1130-1134. 1981
- Enhanced alpha-adrenoreceptor-mediated vasoconstriction in essential hypertension.. Hypertension. 3:I119-I123. 1981
- BETA ADRENOCEPTOR AND ALPHA ADRENOCEPTOR BLOCKERS IN THE ANTIHYPERTENSIVE THERAPY PLAN - RECOMMENDATIONS FOR PRACTICE. Therapeutische Umschau. Revue therapeutique. 38:17-23. 1981
- Decrease in α-Adrenoceptor-Mediated Vasoconstriction Parallels the Antihypertensive Response to Propranolol in Patients with Normal Renin Essential Hypertension. Clinical Science. 61:445s-448s. 1981
- ENHANCED ALPHA-ADRENORECEPTOR-MEDIATED VASOCONSTRICTION IN ESSENTIAL-HYPERTENSION. Hypertension. 3:119-123. 1981
- Elevated Plasma Adrenaline Reflects Sympathetic Overactivity and Enhanced α-Adrenoceptor-Mediated Vasoconstriction in Essential Hypertension. Clinical Science. 61:161s-164s. 1981
- [Beta and alpha-adrenoceptor blockers in the planning of anti-hypertensive therapy: recommendations for general practice].. Therapeutische Umschau. Revue therapeutique. 38 Suppl:17-23. 1981
- [Enhanced alpha adrenoreceptor-mediated vasoconstrictor component in essential hypertension].. Swiss Medical Weekly Schweizerische Medizinische Wochenschrift. 110:1941-1944. 1980
- Atenolol v placebo in mild hypertension: renal metabolic and stress antipressor effects.. British Journal of Clinical Pharmacology. 9:553-560. 1980
- Antihypertensive Response to Postsynaptic α-Blockade with Prazosin in Low- and Normal-Renin Hypertension. Journal of Cardiovascular Pharmacology. 2:S399-S405. 1980
- Intrarenal Blood Flow Distribution in the Genetically Hypertensive Rat. Nephron Nephron - Clinical Practice Nephron - Experimental Nephrology Nephron - Physiology Experimental Nephrology. 26:49-52. 1980
- Plasma Catecholamines and Cardiac, Renal and Peripheral Vascular Adrenoceptor-Mediated Responses in Different Age Groups of Normal and Hypertensive Subjects. Clinical and Experimental Hypertension Clinical and Experimental Hypertension - Part A Theory and Practice Clinical and Experimental Hypertension. 2:409-426. 1980
- The concept of beta-adrenoreceptor blockade in the primary and secondary prevention of cardiac mortality and morbidity.. Triangle. 19:35-45. 1980
- Antihypertensive efficacy of a new long acting hydralazine like vasodilator, ISF 2469 in combination with a betablocker and a diuretic.. International Journal of Clinical Pharmacology and Biopharmacy. 17:380-385. 1979
- Studies on tienilic acid in hypertensive hyperuricaemic patients in Dunedin, New Zealand.. Postgraduate Medical Journal. 55 Suppl 3:85-91. 1979
- COMPARISON OF TIENILIC ACID WITH CYCLOPENTHIAZIDE IN HYPERURICÆMIC HYPERTENSIVE PATIENTS. The Lancet. 312:595-598. 1978
- [The potential of beta-blockaders in the management of hypertension].. Der Internist. 19:510-519. 1978
- Effects of prazosin in patients with hypertension. Clinical Pharmacology and Therapeutics. 20:138-141. 1976
- Experience with labetalol in hypertension.. British Journal of Clinical Pharmacology. 3:765-771. 1976
- EXPERIENCE WITH LABETALOL IN HYPERTENSION. British Journal of Clinical Pharmacology. 3:765-771. 1976
- INTRARENAL BLOOD-FLOW DISTRIBUTION IN GENETICALLY HYPERTENSIVE (GH) RAT. Clinical and Experimental Pharmacology and Physiology. 51-54. 1976
-
conference paper
- PP.32.23. Journal of Hypertension. e426-e427. 2015
- ASSESSMENT OF STANDARDIZED BLOOD PRESSURE MEASUREMENT PROTOCOLS: DEFINING ESSENTIAL AND LESS ESSENTIAL CRITERIA. Canadian Journal of Cardiology. S301-S301. 2013
- MEASUREBP: IDENTIFYING EVIDENCE-BASED THRESHOLD AND TARGET VALUES FOR NEWER AUTOMATED METHODS OF MEASURING BLOOD PRESSURE. Canadian Journal of Cardiology. S301-S302. 2013
- Upper airway obstruction caused by multicentric reticulohistocytosis. Allergy: European Journal of Allergy and Clinical Immunology. 719-720. 2011
- Cholesterol reduction in cyclosporine-treated renal transplant patients: effect on platelet-derived growth factor levels and platelet activation. Transplantation Proceedings. 2591-2592. 1997
- Duration of action and BP control in patients with partial compliance: Amlodipine vs. diltiazem.. Hypertension. 213-213. 1997
- SERUM PLATELET-DERIVED GROWTH-FACTOR (PDGF) IN CYCLOSPORINE (CSA)-TREATED RENAL-TRANSPLANT (TX) PATIENTS (PTS) - CORRELATION WITH PARATHYROID-HORMONE (PTH) AND CHOLESTEROL LEVELS. Journal of the American Society of Nephrology : JASN. 1113-1113. 1995
- ANTIHYPERTENSIVE TREATMENT REDUCES PLATELET ACTIVATION AND PLATELET-DERIVED GROWTH-FACTOR (PDGF) IN BORDERLINE HYPERTENSIVE DIABETIC-PATIENTS. Hypertension. 1395-1395. 1995
- Smoking, antihypertensive treatment benefit, and comprehensive antihypertensive treatment approach: some thoughts on the results of the International Prospective Primary Prevention Study in Hypertension.. Journal of Cardiovascular Pharmacology. S77-S80. 1990
- CHRONIC QUINAPRIL THERAPY ATTENUATES HEART-RATE AND CATECHOLAMINE RESPONSES TO THE VALSALVA MANEUVER. Clinical Research. A400-A400. 1989
- CILAZAPRIL MITIGATES THE FALL IN FOREARM BLOOD-FLOW ASSOCIATED WITH THE VALSALVA MANEUVER. Clinical Research. A394-A394. 1989
- THE ANTIHYPERTENSIVE ACTION OF CHRONIC ONCE-A-DAY CILAZAPRIL THERAPY. Clinical Research. A401-A401. 1989
- INCREASE OF CYTOSOLIC CALCIUM IN PLATELETS OF DAHL SENSITIVE RATS FED A HIGH SALT DIET. Hypertension. 349-349. 1988
- THE RESTING ELECTROCARDIOGRAM PREDICTS SUDDEN-DEATH IN HYPERTENSIVE PATIENTS - THE CARDIAC-INFARCTION INJURY SCORE. Hypertension. 352-352. 1988
- PREVALENCE OF INCREASED ELECTROCARDIOGRAPHIC ISCHEMIC-INJURY IN INDIVIDUALS WITH THE CORONARY PRONE BEHAVIOR PATTERN (TYPE-A). Psychosomatic Medicine. 204-204. 1987
- ELECTROCARDIOGRAPHIC CHANGES DURING ANTIHYPERTENSIVE THERAPY IN THE INTERNATIONAL PROSPECTIVE PRIMARY PREVENTION STUDY IN HYPERTENSION (IPPSH). Clinical and Investigative Medicine. B88-B88. 1987
- FOREARM VASCULAR AND NEUROHUMORAL RESPONSES OF HYPERTENSIVE PATIENTS TO CARDIOSELECTIVE BETA-ADRENERGIC-BLOCKADE. Clinical and Investigative Medicine. B61-B61. 1987
- HEMODYNAMIC AND NEUROHUMORAL EFFECTS OF LISINOPRIL IN HYPERTENSIVE PATIENTS. Clinical and Investigative Medicine. B60-B60. 1987
- INHIBITION OF ANGIOTENSIN CONVERTING ENZYME (ACE) ATTENUATES THE CARDIAC AND CATECHOLAMINE (CA) RESPONSES TO THE VALSALVA MANEUVER (VM) IN HYPERTENSIVE PATIENTS. Clinical and Investigative Medicine. B61-B61. 1987
- MODULATION OF LEFT-VENTRICULAR (LV) HYPERTROPHY BY DIETARY SALT AND INHIBITION OF ANGIOTENSIN CONVERTING ENZYME (ACE). Clinical and Investigative Medicine. B54-B54. 1987
- THE VASODILATOR POTENTIAL OF ATRIAL-NATRIURETIC-PEPTIDE IN PATIENTS WITH ESSENTIAL-HYPERTENSION AND NORMOTENSIVE SUBJECTS. Clinical and Investigative Medicine. B61-B61. 1987
- ATRIAL-NATRIURETIC-PEPTIDE RELEASE IN MAN - CONTROLLED BY WALL STRETCH AND VOLUME. Kidney International. 457-457. 1986
- ELECTROCARDIOGRAPHIC CHANGES DURING ANTIHYPERTENSIVE THERAPY IN THE INTERNATIONAL PROSPECTIVE PRIMARY PREVENTION STUDY IN HYPERTENSION (IPPPSH). Hypertension. 824-824. 1986
- NATRIURETIC AND VASODILATOR THRESHOLD OF ATRIAL-NATRIURETIC-PEPTIDE IN MAN. Hypertension. 824-824. 1986
- ATRIAL-NATRIURETIC-PEPTIDE INDUCES POTENT VASODILATION IN THE HUMAN FOREARM AND THIS IS ANTAGONIZED BY NORADRENALINE. Blood Vessels. 60-60. 1986
- Atrial Natriuretic Peptide Release in Man: Wall Stretch and Sympathetic Nerve Control. Clinical and Experimental Hypertension Clinical and Experimental Hypertension - Part A Theory and Practice Clinical and Experimental Hypertension. 131-151. 1986
- THE ANTIRENIN-ANGIOTENSIN ACTION OF ATRIAL-NATRIURETIC-PEPTIDE IN MAN. Journal of Cardiovascular Pharmacology. 1293-1294. 1986
- Influence of Salt Balance on Plasma Levels of Atrial Natriuretic Factor, Renin and Noradrenaline in Man. Journal of Hypertension. 663-663. 1985
- INCREASED ADRENALINE-STIMULATED CALCIUM-ACTIVATED, PHOSPHOLIPID DEPENDENT PHOSPHORYLATION IN ESSENTIAL-HYPERTENSION. Clinical Research. A280-A280. 1985
- PLASMA ATRIAL NATRIURETIC FACTOR IN MAN - PARALLEL CHANGES WITH RENIN, NORADRENALINE AND SALT BALANCE. Hypertension. 838-838. 1985
- ADRENALINE-INDUCED ALPHA-2 ADRENOCEPTOR MEDIATED VASOCONSTRICTOR RESPONSE IN NORMOTENSIVE SUBJECTS AND IN PATIENTS WITH ESSENTIAL-HYPERTENSION. Clinical Research. A328-A328. 1984
- EPINEPHRINE STIMULATES CALCIUM-DEPENDENT PROTEIN-PHOSPHORYLATION IN HUMAN-PLATELETS. Clinical Research. A239-A239. 1984
- ADRENALINE-INDUCED ALPHA-2 ADRENOCEPTOR MEDIATED VASOCONSTRICTOR RESPONSE IN NORMOTENSIVE SUBJECTS AND IN PATIENTS WITH ESSENTIAL-HYPERTENSION. Clinical Research. A843-A843. 1983
- EPINEPHRINE STIMULATES CALCIUM-DEPENDENT PROTEIN-PHOSPHORYLATION IN HUMAN-PLATELETS. Clinical Research. A833-A833. 1983
- GREATER REDUCTION OF VASCULAR-RESISTANCE FOLLOWING CALCIUM ENTRY BLOCKADE AS COMPARED TO REPERFUSION AFTER ARTERIAL-OCCLUSION IN ESTABLISHED ESSENTIAL-HYPERTENSION. Blood Vessels. 198-198. 1983
- VERAPAMILS VASODILATATORY AND ANTIHYPERTENSIVE EFFICACY OFFERS AN ALTERNATIVE TREATMENT CONCEPT IN OLDER AND LOW RENIN ESSENTIAL HYPERTENSIVE PATIENTS. Kidney International. 280-280. 1983
- ELEVATED PLASMA ADRENALINE REFLECTS SYMPATHETIC OVERACTIVITY AND ENHANCED ALPHA-ADRENOCEPTOR MEDIATED VASOCONSTRICTION IN ESSENTIAL-HYPERTENSION. European Journal of Clinical Investigation. 1-1. 1981
- ENHANCED ALPHA-ADRENORECEPTOR-MEDIATED VASOCONSTRICTION CONTRIBUTES TO ELEVATED PERIPHERAL RESISTANCE IN ESSENTIAL-HYPERTENSION. Blood Vessels. 208-208. 1981
- UPTAKE OF ALPHA-ADRENORECEPTOR-MEDIATED VASOCONSTRICTION UNDER BETA-BLOCKADE IN PATIENTS WITH ESSENTIAL-HYPERTENSION. Swiss Medical Weekly Schweizerische Medizinische Wochenschrift. 1737-1738. 1981
- VASODILATOR POTENCY OF INTRA-ARTERIAL VERAPAMIL AS COMPARED TO SODIUM-NITROPRUSSIDE. European Journal of Clinical Investigation. 16-16. 1981
- PHARMACOKINETICS OF METOPROLOL IN HYPERTENSIVE PATIENTS. Clinical and Experimental Pharmacology and Physiology. 293-294. 1978